Version 1
: Received: 11 October 2020 / Approved: 12 October 2020 / Online: 12 October 2020 (10:14:44 CEST)
Version 2
: Received: 1 December 2020 / Approved: 1 December 2020 / Online: 1 December 2020 (15:09:12 CET)
Version 3
: Received: 30 March 2021 / Approved: 30 March 2021 / Online: 30 March 2021 (09:32:47 CEST)
How to cite:
Uyeda, M.; Subramanian, M. Screening and Identification of New Biomarkers for the Control of Cervical Cancer. Preprints2020, 2020100220. https://doi.org/10.20944/preprints202010.0220.v1
Uyeda, M.; Subramanian, M. Screening and Identification of New Biomarkers for the Control of Cervical Cancer. Preprints 2020, 2020100220. https://doi.org/10.20944/preprints202010.0220.v1
Uyeda, M.; Subramanian, M. Screening and Identification of New Biomarkers for the Control of Cervical Cancer. Preprints2020, 2020100220. https://doi.org/10.20944/preprints202010.0220.v1
APA Style
Uyeda, M., & Subramanian, M. (2020). Screening and Identification of New Biomarkers for the Control of Cervical Cancer. Preprints. https://doi.org/10.20944/preprints202010.0220.v1
Chicago/Turabian Style
Uyeda, M. and Mahendran Subramanian. 2020 "Screening and Identification of New Biomarkers for the Control of Cervical Cancer" Preprints. https://doi.org/10.20944/preprints202010.0220.v1
Abstract
Cervical cancer (CC) is the most common cancer in women worldwide and is almost always associated with repeated infections by human papillomavirus (HPV). Screening by traditional tests associated with biomarker identification techniques for low- or high-grade injuries, are becoming increasingly important in diagnosis and prognosis, avoiding countless deaths. This article explores existing literature on the main serum biomarkers and the identification of biomarkers associated with the oncogenesis of HPV expression in the identification of pre-cancerous lesions and of CC for an effective treatment, with reduction of recurrence, as well as we explain strategies for the development of biomarkers based on DNA, proteins and other markers. We also describe how markers of chromosomal instability host DNA, promoting hypo- or hypermethylation of DNA, as well as polymorphisms and epigenetic events in the p53 gene. Finally, we discuss changes in gene expression using cDNA microarray techniques and changes in the expression of proteins and markers identified through mass spectrometry (MS).
Keywords
Cervical cancer; Biomarkers; Human papillomavirus; Pap smear; cervical intraepithelial neoplasia
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
